Security key
45845P108
- Security type / class
- Equity / COM
- Total 13F shares
- 25,849,561
- Total 13F value
- $3,203,186,181
- Share change
- -361,265
- Put/Call ratio
- 106%
- SEC-reported price per share
- $123.92
- Number of holders
- 210
- Value change
- +$17,921,567
- Number of buys
- 104
- Number of sells
- 92
Open additional details 1 more signal available
Report period
Q4 2019
Institutions
210
Top holders
10
Broader feeds
Ownership snapshot
Top reported holders of ICPT - INTERCEPT PHARMACEUTICALS IN - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q4 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
210
Shares
25,849,561
Rows available
210
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
183
Q4 2019 holders
210
Holder diff
27
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 value | Q4 2019 value | Value change | Value Chg % |
|---|